The influence of genetic variants in selenoprotein genes on disease stage was further supported by observations that rs7579 (SEPP1) and rs17650792 and rs1800668 (GPX1) modulate risk for advanced PCA stages [52]. This evidence concerns the gene GPX1 and posterior cortical atrophy.